HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

作者: J Allen McCutchan , Julia W Wu , Kevin Robertson , Susan L Koletar , Ronald J Ellis

DOI: 10.1097/QAD.0B013E3280EF6ACD

关键词:

摘要: Introduction HIV can damage neurons leading to cognitive impairment. Epidemiological observations suggest that neuropsychological impairment might progress despite successful HAART therapy, but available prevalence estimates are based on populations were selected for Methods Of 433 advanced AIDS patients with documented immune reconstitution (CD4 lymphocyte counts 100 cells/microl after HAART), 286 had brief assessments of cognition (Trailmaking A/B and Digit Symbol Tests) at least once, no confounding neurological conditions, norms comprehensive demographic corrections. At entry, most reconstituted (median CD4 cell count 230 cells/microl) was suppressed (65% 20 000 RNA copies/ml). Results Over one quarter (27%) participants exhibited their initial assessment, a rate nearly twice expected in normal (HIV-uninfected) reference population (14%). These impaired did not differ from the unimpaired group respect age, sex, education, race, counts, or HIV-RNA levels. Improved performance tests over 2-year period 3-5 years initiating HAART. This improvement marginally associated continued improving control plasma levels, concurrent levels recovery counts). Conclusion Most responding prolonged periods have stable cognition, remain more likely be than general population. During HAART, test probably reflects both practice effects continuing 3

参考文章(32)
Valerio Tozzi, Pietro Balestra, Patrizia Lorenzini, Rita Bellagamba, Simonetta Galgani, Angela Corpolongo, Chrysoula Vlassi, Dora Larussa, Mauro Zaccarelli, Pasquale Noto, Ubaldo Visco-Comandini, Marinella Giulianelli, Giuseppe Ippolito, Andrea Antinori, Pasquale Narciso, Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. Journal of NeuroVirology. ,vol. 11, pp. 265- 273 ,(2005) , 10.1080/13550280590952790
Steven Paul Woods, Meredith Childers, Ronald J Ellis, Stephanie Guaman, Igor Grant, Robert K Heaton, HIV Neurobehavioral Research Center (HNRC) Group 1, A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology. ,vol. 21, pp. 83- 89 ,(2006) , 10.1016/J.ACN.2005.07.008
S. Thomas, Anti-HIV drug distribution to the central nervous system. Current Pharmaceutical Design. ,vol. 10, pp. 1313- 1324 ,(2004) , 10.2174/1381612043384835
Gregory J. Dore, Patricia K. Correll, Yueming Li, John M. Kaldor, David A. Cooper, Bruce J. Brew, Changes to AIDS dementia complex in the era of highly active antiretroviral therapy AIDS. ,vol. 13, pp. 1249- 1253 ,(1999) , 10.1097/00002030-199907090-00015
Andrea Cossarizza, Graeme Moyle, Antiretroviral nucleoside and nucleotide analogues and mitochondria. AIDS. ,vol. 18, pp. 137- 151 ,(2004) , 10.1097/00002030-200401230-00002
K. A. Jellinger, U. Setinek, M. Drlicek, G. Böhm, A. Steurer, F. Lintner, Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathologica. ,vol. 100, pp. 213- 220 ,(2000) , 10.1007/S004010000245
Scott L. Letendre, J. Allen McCutchan, Meredith E. Childers, Steven P. Woods, Deborah Lazzaretto, Robert K. Heaton, Igor Grant, Ronald J. Ellis, , Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders Annals of Neurology. ,vol. 56, pp. 416- 423 ,(2004) , 10.1002/ANA.20198
T. L. Jernigan, S. Archibald, J. R. Hesselink, J. H. Atkinson, R. A. Velin, J. A. McCutchan, J. Chandler, I. Grant, , Magnetic Resonance Imaging Morphometric Analysis of Cerebral Volume Loss in Human Immunodeficiency Virus Infection JAMA Neurology. ,vol. 50, pp. 250- 255 ,(1993) , 10.1001/ARCHNEUR.1993.00540030016007
Catherine L. Carey, Steven Paul Woods, Raul Gonzalez, Emily Conover, Thomas D. Marcotte, Igor Grant, Robert K. Heaton, Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology. ,vol. 26, pp. 307- 319 ,(2004) , 10.1080/13803390490510031
Ronald J Ellis, Scott R Evans, David B Clifford, Lauren R Moo, Justin C McArthur, Ann C Collier, Constance Benson, Ron Bosch, David Simpson, Constantin T Yiannoutsos, Yijun Yang, Kevin Robertson, Neurological AIDS Research Consortium, AIDS Clinical Trials Group Study Teams A5001 and A362, None, Clinical validation of the NeuroScreen Journal of NeuroVirology. ,vol. 11, pp. 503- 511 ,(2005) , 10.1080/13550280500384966